catumaxomab monoclonal antibody drug. targets cd3 and epcam. used in treatment of malignant ascites. generic name and stylized

adhesion antibody ascites biological biosimilar biotech biotechnology cancer catumaxomab cavity cd3 cell disease drug epcam epithelial fluid hybrid immunoglobulin immunology infusion injection inn mab malignant metastasis molecule monoclonal nomenclature oncology peptide peritoneal protein ratmouse tumor